High expression of GLI1 is associated with better survival in advanced SCLC

Summary. Aim: Aberrant Sonic hedgehog (Shh) pathway signaling has been described in small cell lung cancer (SCLC), as well discrepancies, when analyzing expression of pathway components in SCLC cell lines vs tumor biopsies. Shh key component GLI1 was evaluated in advanced SCLC and data corr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Datum:2023
Hauptverfasser: Kozirovskis, V., Zandberga, E., Magone, M., Purkalne, G., Linē, A., Vikmanis, U.
Format: Artikel
Sprache:English
Veröffentlicht: PH Akademperiodyka 2023
Schlagworte:
Online Zugang:https://exp-oncology.com.ua/index.php/Exp/article/view/2020-1-13
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Experimental Oncology

Institution

Experimental Oncology
id oai:ojs2.ex.aqua-time.com.ua:article-209
record_format ojs
spelling oai:ojs2.ex.aqua-time.com.ua:article-2092023-10-11T16:42:32Z High expression of GLI1 is associated with better survival in advanced SCLC High expression of GLI1 is associated with better survival in advanced SCLC Kozirovskis, V. Zandberga, E. Magone, M. Purkalne, G. Linē, A. Vikmanis, U. GLI1, prognosis, small cell lung cancer, Sonic hedgehog pathway, survival GLI1, prognosis, small cell lung cancer, Sonic hedgehog pathway, survival Summary. Aim: Aberrant Sonic hedgehog (Shh) pathway signaling has been described in small cell lung cancer (SCLC), as well discrepancies, when analyzing expression of pathway components in SCLC cell lines vs tumor biopsies. Shh key component GLI1 was evaluated in advanced SCLC and data correlated with patient survival. Materials and Methods: GLI1 expression was analyzed by quantitative real-time polymerase chain reaction in pre-treatment fresh frozen tumor biopsies of 12 advanced SCLC patients and mRNA level of GLI1 was compared in short-term vs long-term survivor’s samples (stratified by median survival, independent samples t-test). Results: Expression of GLI1 mRNA was significantly higher in long-term (> 9.6 months, n = 6) survivor’s biopsies than in short-term (≤ 9.6 months, n = 6) survivors (p = 0.0196, 95% CI: 0.000016 to 0.000147, two-tailed independent samples t-test). Conclusion: High GLI1 mRNA expression in SCLC was found to be positive prognostic marker associated with longer survival. Further research is needed for validation of these results due to the small number of patients in the study. Summary. Aim: Aberrant Sonic hedgehog (Shh) pathway signaling has been described in small cell lung cancer (SCLC), as well discrepancies, when analyzing expression of pathway components in SCLC cell lines vs tumor biopsies. Shh key component GLI1 was evaluated in advanced SCLC and data correlated with patient survival. Materials and Methods: GLI1 expression was analyzed by quantitative real-time polymerase chain reaction in pre-treatment fresh frozen tumor biopsies of 12 advanced SCLC patients and mRNA level of GLI1 was compared in short-term vs long-term survivor’s samples (stratified by median survival, independent samples t-test). Results: Expression of GLI1 mRNA was significantly higher in long-term (> 9.6 months, n = 6) survivor’s biopsies than in short-term (≤ 9.6 months, n = 6) survivors (p = 0.0196, 95% CI: 0.000016 to 0.000147, two-tailed independent samples t-test). Conclusion: High GLI1 mRNA expression in SCLC was found to be positive prognostic marker associated with longer survival. Further research is needed for validation of these results due to the small number of patients in the study. PH Akademperiodyka 2023-06-01 Article Article application/pdf https://exp-oncology.com.ua/index.php/Exp/article/view/2020-1-13 10.32471/exp-oncology.2312-8852.vol-42-no-1.14266 Experimental Oncology; Vol. 42 No. 1 (2020): Experimental Oncology; 75-77 Експериментальна онкологія; Том 42 № 1 (2020): Експериментальна онкологія; 75-77 2312-8852 1812-9269 10.32471/exp-oncology.2312-8852.vol-42-no-1 en https://exp-oncology.com.ua/index.php/Exp/article/view/2020-1-13/2020-1-13 Copyright (c) 2023 Experimental Oncology https://creativecommons.org/licenses/by-nc/4.0/
institution Experimental Oncology
baseUrl_str
datestamp_date 2023-10-11T16:42:32Z
collection OJS
language English
topic GLI1
prognosis
small cell lung cancer
Sonic hedgehog pathway
survival
spellingShingle GLI1
prognosis
small cell lung cancer
Sonic hedgehog pathway
survival
Kozirovskis, V.
Zandberga, E.
Magone, M.
Purkalne, G.
Linē, A.
Vikmanis, U.
High expression of GLI1 is associated with better survival in advanced SCLC
topic_facet GLI1
prognosis
small cell lung cancer
Sonic hedgehog pathway
survival
GLI1
prognosis
small cell lung cancer
Sonic hedgehog pathway
survival
format Article
author Kozirovskis, V.
Zandberga, E.
Magone, M.
Purkalne, G.
Linē, A.
Vikmanis, U.
author_facet Kozirovskis, V.
Zandberga, E.
Magone, M.
Purkalne, G.
Linē, A.
Vikmanis, U.
author_sort Kozirovskis, V.
title High expression of GLI1 is associated with better survival in advanced SCLC
title_short High expression of GLI1 is associated with better survival in advanced SCLC
title_full High expression of GLI1 is associated with better survival in advanced SCLC
title_fullStr High expression of GLI1 is associated with better survival in advanced SCLC
title_full_unstemmed High expression of GLI1 is associated with better survival in advanced SCLC
title_sort high expression of gli1 is associated with better survival in advanced sclc
title_alt High expression of GLI1 is associated with better survival in advanced SCLC
description Summary. Aim: Aberrant Sonic hedgehog (Shh) pathway signaling has been described in small cell lung cancer (SCLC), as well discrepancies, when analyzing expression of pathway components in SCLC cell lines vs tumor biopsies. Shh key component GLI1 was evaluated in advanced SCLC and data correlated with patient survival. Materials and Methods: GLI1 expression was analyzed by quantitative real-time polymerase chain reaction in pre-treatment fresh frozen tumor biopsies of 12 advanced SCLC patients and mRNA level of GLI1 was compared in short-term vs long-term survivor’s samples (stratified by median survival, independent samples t-test). Results: Expression of GLI1 mRNA was significantly higher in long-term (> 9.6 months, n = 6) survivor’s biopsies than in short-term (≤ 9.6 months, n = 6) survivors (p = 0.0196, 95% CI: 0.000016 to 0.000147, two-tailed independent samples t-test). Conclusion: High GLI1 mRNA expression in SCLC was found to be positive prognostic marker associated with longer survival. Further research is needed for validation of these results due to the small number of patients in the study.
publisher PH Akademperiodyka
publishDate 2023
url https://exp-oncology.com.ua/index.php/Exp/article/view/2020-1-13
work_keys_str_mv AT kozirovskisv highexpressionofgli1isassociatedwithbettersurvivalinadvancedsclc
AT zandbergae highexpressionofgli1isassociatedwithbettersurvivalinadvancedsclc
AT magonem highexpressionofgli1isassociatedwithbettersurvivalinadvancedsclc
AT purkalneg highexpressionofgli1isassociatedwithbettersurvivalinadvancedsclc
AT linea highexpressionofgli1isassociatedwithbettersurvivalinadvancedsclc
AT vikmanisu highexpressionofgli1isassociatedwithbettersurvivalinadvancedsclc
first_indexed 2025-07-17T12:16:34Z
last_indexed 2025-07-17T12:16:34Z
_version_ 1837896401760026624